Electrocautery ablation of high-grade anal intraepithelial lesions

JRCT ID: jRCTs032230341

Registered date:12/09/2023

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Anal intraepithelial neoplasia
• Date of first enrollment: 27/09/2023
• Target sample size: 100
• Study type: Interventional
• Intervention(s): Electrocautery ablation therapy using Surgitron dual EMC for anal intraepithelial neoplasia

Outcome(s)

• Primary Outcome: Eradication rate of anal intraepithelial neoplasia at 12 months after the treatment

Secondary Outcome

Eradication rate of anal intraepithelial neoplasia at each visit after the treatment
Adverse effect

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

(1) Subjects who have given written consent to participate in the study.
(2) Person aged 18 years or older.
(3) Patients with a diagnosis of anal intraepithelial neoplasia based on the results of the pathological finding

Exclude criteria

(1) Invasive cancer
(2) Patients whom the principal investigator judges to be inappropriate for inclusion in the study.
(3) pregnant or breastfeeding woman

Related Information

• Primary Sponsor: Ando Naokatsu
• Source(s) of Monetary Support: National Center for Global Health and Medicine